MENU
PSTV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Plus Therapeutics (PSTV) Ownership - Who owns Plus Therapeutics?
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases... Show more
Profile
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 737 255-7194
Employees
20
Web
https://www.plustherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.12M
P/E Ratio
N/A
Total Cash
9.87M
Projected Growth
N/A
Total Debt
40K
Revenue
N/A
Risk (Beta)
0.64
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PSTV
Capitalization
15.1M
P/E Ratio
N/A
Risk (Beta)
0.64
Dividend Yield
N/A
Total Cash
9.87M
Total Cash/Share
0.19
Total Debt
40K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-23.64M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-2.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17K
Current Ratio
1.03
Current Revenue Per Employee
13176.47
Dividends Per Share - Security
N/A
EBITDA
-22.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.49
Revenue To Assets
-306.82
Shares Held By Institutions
304K
Shares Outstanding - Current
51M
Total Liabilities
35.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-74.226
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 737 255-7194
Employees
20
Web
https://www.plustherapeutics.com